Clinical Trials on Moderate-to-severe Atopic Dermatitis
Total 1875 results
-
Bristol-Myers SquibbNot yet recruitingModerate-to-severe Plaque PsoriasisKorea, Republic of
-
Novartis PharmaceuticalsRecruitingModerate-to-severe Plaque PsoriasisRussian Federation
-
Kyowa Kirin Korea Co., Ltd.CompletedModerate to Severe Plaque PsoriasisKorea, Republic of
-
UCB Biopharma SRLCompletedModerate to Severe Plaque PsoriasisKorea, Republic of
-
Novartis PharmaceuticalsCompletedModerate-to-severe Plaque PsoriasisIndonesia
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisGermany
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...UnknownModerate to Severe Plaque PsoriasisChina
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
Jiangsu HengRui Medicine Co., Ltd.UnknownModerate-to-severe Plaque PsoriasisChina
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisCzech Republic, Estonia, Hungary, Israel, Romania, Slovakia, Slovenia, Ukraine
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
AbbottWithdrawnModerate to Severe Plaque Psoriasis
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingModerate-to-Severe Plaque PsoriasisChina
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingModerate to Severe Plaque PsoriasisChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingModerate-to-Severe Plaque Psoriasis
-
IpsenRecruitingModerate to Severe Upper Facial LinesGermany, France
-
Sun Pharmaceutical Industries LimitedRecruitingModerate to Severe Plaque PsoriasisUnited States, El Salvador
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdActive, not recruitingModerate-to-Severe Plaque PsoriasisChina
-
Hangzhou Highlightll Pharmaceutical Co., LtdCompletedModerate to Severe Plaque PsoriasisChina
-
Samsung Bioepis Co., Ltd.CompletedPsoriasis | Moderate to Severe Plaque PsoriasisCzechia, Estonia, Hungary, Korea, Republic of, Latvia, Lithuania, Poland, Ukraine
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin China Pharmaceutical Co., LTD.WithdrawnModerate to Severe Plaque PsoriasisChina
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
University of Illinois at ChicagoJohnson & Johnson Vision Care, Inc.UnknownModerate to Severe Dry Eye DiseaseUnited States
-
Rigshospitalet, DenmarkOslo University HospitalRecruiting
-
University of California, San FranciscoCompletedModerate to Severe PsoriasisUnited States
-
Biosplice Therapeutics, Inc.CompletedModerate to Severe OsteoarthritisUnited States
-
Tufts Medical CenterCentocor, Inc.CompletedModerate to Severe Palmar Plantar PsoriasisUnited States
-
NovartisCompletedModerate to Severe HypertensionRussian Federation, Romania, Singapore, Spain, Germany, Philippines
-
AbbVie (prior sponsor, Abbott)Paragon BiomedicalCompletedModerate to Severe Plaque PsoriasisUnited States
-
Santen SASCompletedModerate to Severe Dry Eye SyndromeFrance
-
Dong-A ST Co., Ltd.Meiji Seika Pharma Co., Ltd.CompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Estonia, France, Canada
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Wake Forest University Health SciencesGalderma R&DActive, not recruiting
-
CelltrionRecruitingModerate to Severe Chronic Plaque PsoriasisEstonia
-
Biocon Biologics UK LtdActive, not recruitingModerate to Severe Chronic Plaque PsoriasisUnited States
-
Astellas Pharma IncBiogenCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingModerate to Severe Acne VulgarisChina
-
PollogenLumenis Be Ltd.RecruitingModerate to Severe Acne VulgarisUnited States
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingModerate to Severe Chronic Plaque PsoriasisChina
-
Sun Pharmaceutical Industries LimitedRecruitingModerate-to-severe Chronic Plaque PsoriasisUnited States, Hungary, India, Poland, Slovakia, Spain
-
Novartis PharmaceuticalsActive, not recruitingModerate to Severe Chronic Plaque PsoriasisChina
-
Nektar TherapeuticsTerminatedModerate to Severe Chronic PainUnited States
-
Boston PharmaceuticalsCompletedModerate to Severe Acne VulgarisUnited States, Canada
-
Mundipharma Research GmbH & Co KGCompletedModerate to Severe Idiopathic RLS With Daytime SymptomsSpain, Sweden, Germany